Symptom Management After Breast Cancer Surgery



Status:Completed
Conditions:Breast Cancer, Neurology
Therapuetic Areas:Neurology, Oncology
Healthy:No
Age Range:18 - Any
Updated:6/30/2018
Start Date:September 2003
End Date:December 2007

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery

This trial is part of a larger, longitudinal study of symptoms that occur in the breast
surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop
pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a
lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women
who wear the lidocaine patch will report a decrease in pain and decreased interference with
function compared to women who wear the placebo patch.


Inclusion Criteria:

- Adult women >18 years who develop neuropathic pain in the breast scar area and/or
ipsilateral arm following breast cancer surgery

- Has a healed incision(s)

- Has no recurrent disease in the painful area

- Is able to read, write and understand English

Exclusion Criteria:

- Presence of another type of pain that is more severe than the neuropathic pain

- Use of an opioid analgesic of greater than 60 mg codeine/day

- Is actively trying to become pregnant

- Has a medical contraindication to the use of lidocaine

- Has an allergy to lidocaine

- Is taking a coanalgesic for neuropathic pain.
We found this trial at
1
site
UCSF Comprehensive Cancer Center
San Francisco, California 94115
?
mi
from
San Francisco, CA
Click here to add this to my saved trials